Revvity stock hits 52-week low at 87.63 USD

Published 01/08/2025, 14:34
Revvity stock hits 52-week low at 87.63 USD

Revvity Inc’s stock has reached a new 52-week low, closing at 87.63 USD. According to InvestingPro analysis, the $10.36 billion market cap company appears undervalued at current levels, with a perfect Piotroski Score of 9 indicating strong financial health. This marks a significant downturn for the company, which has experienced a 28.91% decline over the past year, with YTD returns at -21.08%. The stock’s performance reflects broader challenges faced by the company, as it navigates a competitive market environment and potential internal adjustments. Despite the decline, the company maintains strong fundamentals with a current ratio of 3.33, indicating solid liquidity. InvestingPro subscribers have access to 10+ additional key insights about Revvity’s financial position. Investors are closely monitoring Revvity’s strategy and financial health as the company seeks to rebound from its current position. The company maintains an overall "GOOD" Financial Health Score of 2.65 according to InvestingPro’s comprehensive analysis, available in the detailed Pro Research Report.

In other recent news, Revvity Inc. reported its second-quarter 2025 earnings, which surpassed analyst expectations with an adjusted earnings per share of $1.18, compared to the forecasted $1.14. The company’s revenue reached $720 million, exceeding the anticipated $710.39 million. Despite these positive financial results, several analysts have adjusted their price targets for Revvity, citing challenges in the Chinese market. Stifel lowered its price target to $110, maintaining a Hold rating, while Raymond (NSE:RYMD) James reduced its target to $115 with an Outperform rating due to reimbursement headwinds in China. Bernstein also set a new target of $115, noting that Revvity’s organic growth matched consensus estimates. Jefferies further decreased its price target to $100, highlighting concerns over China’s drug-related group policies affecting the company’s financial outlook. These recent developments reflect the complex dynamics Revvity faces in maintaining its growth trajectory amidst external pressures.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.